Live AU Certificate Prices Twitter Linkedin-in Youtube Buy and Sell Global RECs Contact

Pharma Company Insures A Healthy Level Of Energy Efficiency Performance In New Facility

Northmore Gordon worked closely with a Singapore- based parts pharmaceutical plant over 2022 to complete an Energy Efficiency Opportunities Assessment for New Ventures as required by Singapore’s National Environment Agency (NEA). The complex requirements of the Program were fully met and the report submitted on time. In addition, NG identified practical energy saving opportunities that are now being implemented as part of the new-build.

The Client 

The International Client is developing a manufacturing facility for pharmaceutical products. It is supported by utilities including Water for Injection (WFI), compressed air, air conditioning and large chiller systems, steam boilers, filling equipment, packaging systems, and cooling towers. 

The Project 

To meet the requirements of the Energy Conservation Act, potential new ventures or major expansion of sites in Singapore sites that use over 54 TJ per annum need to undergo a design review, or Energy Efficiency Opportunity Assessment. 

The upgrades recommended included air-cooled compressors, increase in temperature set points, heat recovery, occupancy sensors, solar PVSolar Photovoltaic, improved perimeter lighting, heat pumps, and optimised boiler sizing. 

Key Facts 

EEOA completed in line with regulation 

Project Details 

Challenges 

Additional Benefits 

Our Role 

Northmore Gordon worked very hard to complete the work to the standard required by the NEA in the line with the development timeframe. This included 

working with the design team, architects, and M&E contractors. The work included a detailed base case energy balance, detailed analysis of the design, identification of energy efficiency opportunities in conjunction with the Client, completion of the NEA’s report template, and achieving sign-off by the Client stakeholders and the NEA. 

A global pharmaceutical manufacturer developing advanced production facilities with sophisticated utilities, precision systems, and stringent quality standards.

Industry

Pharmaceutical

Location

Singapore

Craig Morgan

Sales & Marketing Director

Contact Craig ›

You may also like:

Case Studies

Turning a Regional Utility into an Active Energy Market Participant

Case Studies

Visy Gibson Island: 34,000 t CO2‑e Cut a Year With Waste‑to‑Energy

Case Studies

MainStream Aquaculture: $19K Grant funds a heat pump electrification project

Case Studies

Kalafatis Fresh Produce: $283K in Solar Certificates

Case Studies

Poultry Client Set to Hit 2030 & 2050 Carbon Emissions Targets

Case Studies

Greenham: Moving Towards Decarbonisation

Get in touch

Australia

1300 854 561 (Advisory)

1300 878 500 (Certificates)

Melbourne

Suite 1, Level 4

607 Bourke Street

Melbourne

VIC 3000

Singapore

+65 6690 2480



Singapore

1 Keong Saik Road,

Singapore 089109

Stay up to date

mailto:%20info@northmoregordon.com https://twitter.com/northmoregordon https://www.linkedin.com/company/northmore-gordon-pty-ltd https://www.youtube.com/channel/UCdGc6mABpL2XxVUCrVjYQ1g

Alternatively, complete the form and we will be in

touch with you.

https://northmoregordon.com
Services
Sectors
Upgrades
Certificates
Government Schemes
Helpful Links

What service did Northmore Gordon provide to the pharmaceutical company in this case study?

Northmore Gordon worked with a Singapore-based pharmaceutical plant during 2022 to complete an Energy Efficiency Opportunities Assessment (EEOA) for New Ventures, as required by Singapore's National Environment Agency (NEA).

Where is the pharmaceutical client's facility located and what does it manufacture?

The client is developing a manufacturing facility for pharmaceutical products in Singapore. The facility is supported by utilities including Water for Injection (WFI), compressed air, air conditioning and large chiller systems, steam boilers, filling equipment, packaging systems, and cooling towers.

Why was the pharmaceutical company required to undergo an Energy Efficiency Opportunity Assessment?

Under Singapore's Energy Conservation Act, potential new ventures or major expansions of sites that use over 54 TJ per annum must undergo a design review, or Energy Efficiency Opportunity Assessment (EEOA).

What energy-saving upgrades did Northmore Gordon recommend for the new pharmaceutical facility?

Recommended upgrades included air-cooled compressors, increased temperature set points, heat recovery, occupancy sensors, solar PV, improved perimeter lighting, heat pumps, and optimised boiler sizing.

What were the estimated annual energy and carbon savings from the recommended upgrades?

The estimated annual savings were 11,200 GJ of energy and 560 tCO2e of carbon abatement.

What were the estimated CAPEX, OPEX savings, and payback period for the project?

The project had an estimated CAPEX of approximately $500,000, estimated OPEX savings of approximately $200,000 per year, and a payback period of approximately 2.5 years.

What challenges did the pharmaceutical client face during this project?

Challenges included competitive pressures to provide high-quality service while minimising operating costs, energy bills representing a substantial cost to operations, and the need for any proposed new equipment to gain approval from the client's international parent company before being used.

What additional benefits did the pharmaceutical company gain beyond meeting the NEA requirement?

Additional benefits included lower running costs once the new facility is built and system flexibility while maintaining efficiency.

What was Northmore Gordon's specific role in delivering this project?

Northmore Gordon worked with the design team, architects, and M&E contractors to complete a detailed base case energy balance, detailed analysis of the design, identification of energy efficiency opportunities in conjunction with the client, completion of the NEA's report template, and achieving sign-off from both the client stakeholders and the NEA.

Who is the primary contact associated with this pharmaceutical case study on the Northmore Gordon website?

Craig Morgan, Sales & Marketing Director, is listed as the contact for this case study.

Images on This Page